Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms

Baumeister, Julian; Kranc, Kamil R.; Küstermann, Caroline; Brümmendorf, Tim Henrik; Han, Lijuan; Schuppert, Andreas; Chatain, Nicolas; Koschmieder, Steffen; Hubrich, Annika; Costa, Ivan G.; Zenke, Martin; Denecke, Bernd; Maié, Tiago; Strathmann, Klaus; Seré, Kristin; Sontag, Stephanie; Gezer, Deniz

doi:10.1038/s41375-019-0629-z

%0 Journal Article
%A Baumeister, Julian
%A Chatain, Nicolas
%A Hubrich, Annika
%A Maié, Tiago
%A Costa, Ivan G.
%A Denecke, Bernd
%A Han, Lijuan
%A Küstermann, Caroline
%A Sontag, Stephanie
%A Seré, Kristin
%A Strathmann, Klaus
%A Zenke, Martin
%A Schuppert, Andreas
%A Brümmendorf, Tim Henrik
%A Kranc, Kamil R.
%A Koschmieder, Steffen
%A Gezer, Deniz
%T Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms
%J Leukemia : normal and malignant hemopoiesis
%V 34
%@ 1476-5551
%C London
%I Nature Publishing
%M RWTH-CONV-240289
%P 1062-1074
%D 2020
%Z Published 14 November 2019
%F PUB:(DE-HGF)16
%9 Journal Article
%U <Go to ISI:>//WOS:000522798800009
%$ pmid:31728053
%R 10.1038/s41375-019-0629-z
%U https://publications.rwth-aachen.de/record/774686

h1

h2

h3

h4

h5

h6

RWTH

Kontakt

RWTH Publications

Allgemeines